Physician profile
Richard Essner
NPI 1336163328
$3,981.18
in general payments reported to CMS, 2019-2025
34 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $201 · 2021: $790 · 2022: $745 · 2023: $552 · 2024: $408 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.74 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $895.68 | 2021-2024 | Spy-Phi System |
| E.R. Squibb & Sons, L.L.C. | $483.94 | 2019-2023 | Opdivo |
| Integra Lifesciences Corporation | $426.41 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $398.30 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Array Biopharma INC | $264.32 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $190.57 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $158.49 | 2019-2025 | Enhertu |
| Gilead Sciences, INC. | $126.26 | 2021-2023 | Trodelvy |
| Eisai INC. | $120.79 | 2020-2025 | |
| Caris Mpi, INC. | $106.31 | 2025 | Mi Cancer Seek |
| Dendreon Pharmaceuticals LLC | $104.04 | 2019-2025 | Provenge |
| Baxter Healthcare | $59.85 | 2023 | Floseal |
| Urogen Pharma, INC. | $48.65 | 2025 | |
| Blue Earth Diagnostics | $46.87 | 2023-2024 | |
| Biotissue Holdings INC. | $45.75 | 2021-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $45.71 | 2021 | |
| Myovant Sciences INC. | $44.07 | 2021 | |
| Leica Microsystems INC. | $40.00 | 2019 | |
| Tersera Therapeutics LLC | $38.97 | 2024 | Zoladex |
| Intuitive Surgical, INC. | $32.80 | 2025 | |
| Lilly USA, LLC | $32.42 | 2024 | Verzenio, Retevmo, Jaypirca |
| 180 Medical, INC. | $29.63 | 2024 | |
| Acell, INC. | $28.38 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.87 | 2020 | |
| Progenics Pharmaceuticals, INC. | $22.49 | 2021 | |
| Seagen INC. | $21.98 | 2023 | Padcev |
| Pfizer INC. | $20.82 | 2021 | |
| Foundation Medicine, INC. | $20.28 | 2023 | Foundationone Liquid Cdx |
| Mimedx Group, INC. | $19.67 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $19.15 | 2019 | |
| Immunocore Limited | $18.88 | 2025 | Kimmtrak |
| Immunitybio, INC. | $18.55 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $14.68 | 2019 | |
| Adc Therapeutics America, INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Essner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.